NASDAQ:GHRS • IE000GID8VI0
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GH RESEARCH PLC (GHRS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-06 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2026-03-06 | Needham | Maintains | Buy -> Buy |
| 2026-03-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-23 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-06 | Needham | Maintains | Buy -> Buy |
| 2026-01-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-01-05 | Needham | Reiterate | Buy -> Buy |
| 2025-11-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-13 | Needham | Initiate | Buy |
| 2025-06-24 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-09 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-13 | Guggenheim | Initiate | Buy |
| 2025-03-07 | RBC Capital | Initiate | Outperform |
| 2025-02-27 | Stifel | Maintains | Buy -> Buy |
| 2025-02-13 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-01-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-04 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-07-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 770.90% | N/A 171.26% | N/A 91.55% | N/A 52.49% | N/A 31.36% | |||||||
| EBITDA YoY % growth | N/A | N/A | -15.08M | -30.5M -102.25% | -40.907M -34.12% | -49.997M -22.22% | N/A -18.84% | N/A -32.19% | N/A -26.30% | N/A 15.73% | N/A -21.05% | N/A 110.38% | N/A 3,721.34% | N/A 197.16% | N/A 43.84% | |
| EBIT YoY % growth | -310K | -450K -45.16% | -15.1M -3,255.56% | -30.55M -102.32% | -41.222M -34.93% | -50.312M -22.05% | N/A -25.67% | N/A -87.65% | N/A -16.31% | N/A -15.64% | N/A 31.34% | N/A 163.91% | N/A 425.89% | N/A 102.70% | N/A 47.22% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -0.43 -37.41% | -0.68 -57.77% | -0.75 -10.29% | N/A -12.22% | N/A -100.13% | N/A -9.35% | N/A -9.83% | N/A 17.98% | N/A 114.75% | N/A 1,370.83% | N/A 93.29% | N/A 46.85% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 -62.00% | -0.38 -97.56% | -0.46 -209.40% | -0.54 -135.04% | -0.56 -103.70% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -16.167M -28.01% | -19.278M -52.32% | -21.522M -47.96% | -26.928M -65.02% | -29.172M -80.44% |
| EBIT Q2Q % growth | -18.666M -44.21% | -20.655M -62.23% | -22.848M -55.39% | -27.54M -66.25% | -30.753M -64.75% |
All data in USD
15 analysts have analysed GHRS and the average price target is 33.66 USD. This implies a price increase of 110.64% is expected in the next year compared to the current price of 15.98.
The consensus EPS estimate for the next earnings of GH RESEARCH PLC (GHRS) is -0.28 USD and the consensus revenue estimate is 0 USD.
The number of analysts covering GH RESEARCH PLC (GHRS) is 15.